FOR IN VITRO AND PRE-CLINICAL RESEARCH USE ONLY — NOT APPROVED FOR HUMAN USE
Growth Hormone

HGH 10IU

Recombinant Human Growth Hormone (191aa) — 10 IU per vial. HPLC verified ≥98% purity. For research use only.

From€29.00
In Stock · Ships within 48h
Reviews coming soonBe among the first to share your research experience.
Download Certificate of Analysis
  • EU Dispatch
  • CoA Included — Every Batch
  • Discreet Packaging
Purity≥98% HPLC
FormLyophilised Powder
Storage2–8°C
OriginEuropean Stock
DispatchWithin 48h
SKUUL-HGH-10IU
≥98% PureHPLC verified
HPLC TestedDual identity check
EU DispatchShips within 48h
CoA Incl.Every batch
Research Profile

Why Recombinant Human Growth Hormone Fascinates Researchers

Recombinant human growth hormone — somatotropin — is a 191-amino-acid single-chain protein synthesised by recombinant DNA technology to replicate the sequence of the endogenous hormone secreted by anterior pituitary somatotroph cells. As the most extensively characterised pituitary hormone, it has served as both a therapeutic reference standard and a fundamental research tool for studying GH receptor signalling, body composition regulation, and metabolic physiology.

Recombinant Somatotropin & the GH-IGF-1 Axis

The 191-residue sequence of recombinant human GH is identical to the predominant 22 kDa isoform of pituitary-derived somatotropin. Following subcutaneous administration, GH binds to the GH receptor (GHR), a class I cytokine receptor, triggering receptor dimerisation and activation of the JAK2/STAT5 signalling cascade. STAT5b is the primary transcriptional mediator of hepatic IGF-1 synthesis — the major circulating effector of GH's anabolic effects. The GH-IGF-1 axis represents one of the most thoroughly characterised endocrine signalling systems in mammalian biology, making recombinant GH an essential reference compound for research into growth regulation, metabolic adaptation, and endocrine pharmacology.

GH exerts both direct and IGF-1-mediated effects. Direct effects include activation of hormone-sensitive lipase in adipocytes (promoting lipolysis), modulation of hepatic glucose output, and stimulation of protein synthesis in muscle. IGF-1-mediated effects include promotion of longitudinal bone growth via growth plate chondrocyte stimulation, skeletal muscle hypertrophy, and organ growth. This dual direct/indirect pharmacology makes GH a particularly complex research tool for dissecting metabolic phenotypes.

Body Composition & Metabolic Research

The body composition effects of GH are among its most studied properties in research contexts. GH promotes a shift toward lean body mass through simultaneous lipolytic (fat-mobilising) and anabolic (muscle-preserving) effects. In GH-deficient rodent models — including hypophysectomised rats and dwarf mouse strains — recombinant GH administration restores lean/fat mass ratios, validates the endocrine axis, and enables dose-response characterisation. For in vitro metabolic research, GH stimulation of primary adipocytes, hepatocytes, and myotubes in culture provides tractable systems for interrogating GH receptor downstream signalling.

Research Applications Across Model Systems

Recombinant human GH is used across a wide range of research contexts: as a positive control for GH receptor activation assays, as a comparator in studies of GHRH analogues (tesamorelin) and secretagogues (ipamorelin, CJC-1295 no DAC), and as a tool for reconstituting the GH-IGF-1 axis in hypophysectomised or GH-deficient animal models. It is also used in ageing biology research, where the somatopause — the progressive decline in GH secretory amplitude with advancing age — has been associated with adverse changes in body composition, bone density, and metabolic function.

This content is for informational purposes only and reflects the state of preclinical and clinical research. It does not constitute medical advice, endorsement of human use, or therapeutic claims of any kind.

Manufacturing Standards

Our Quality Commitment

HPLC Verified

Purity confirmed by High-Performance Liquid Chromatography at an accredited EU laboratory.

≥98% Purity

Every batch meets or exceeds 98% purity. CoA available for verification before dispatch.

Batch Traceability

Each vial is traceable to its synthesis batch, testing date, and analytical records.

Cold Chain Storage

European stock stored at optimal temperature from synthesis to dispatch.

48h EU Dispatch

Orders ship from EU stock within 48 hours with discrete, temperature-appropriate packaging.

CoA Included

Certificate of Analysis issued for every batch, available for download on request.

Download CoA for HGH 10IU
Peer-Reviewed Literature

Key Scientific Studies

Peer-reviewed research supporting Recombinant Human Growth Hormone investigation.

[01]
Møller N, Jørgensen JO. (2009) — Endocrine Reviews

“Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects”

Comprehensive review of GH's metabolic pharmacodynamics in human subjects, synthesising data from GH infusion studies, GH deficiency models, and comparative pharmacology. Authors systematically document GH's direct lipolytic effects in adipose tissue, its complex role in hepatic glucose metabolism, and its anabolic effects on protein synthesis in muscle — providing a definitive mechanistic framework for GH metabolic research.

View on PubMed
[02]
Gibney J, Healy ML, Sönksen PH. (2007) — Endocrine Reviews

“The growth hormone/insulin-like growth factor-I axis in exercise and sport”

Systematic evaluation of the GH-IGF-1 axis in the context of physical exercise, muscle adaptation, and body composition regulation. The review examines the acute and chronic GH secretory responses to exercise, the downstream IGF-1-mediated anabolic signalling in muscle and bone, and the research evidence for GH's role in exercise-induced tissue remodelling.

View on PubMed
[03]
Waters MJ, Brooks AJ. (2011) — Journal of Molecular Endocrinology

“Growth hormone receptor: structure function relationships”

Mechanistic review of GH receptor structure-function relationships, covering GHR dimerisation topology, JAK2/STAT5 signalling cascade architecture, and the structural basis for receptor specificity. The review provides the molecular framework for interpreting pharmacological GH receptor studies and understanding how structural features of the 191-residue GH molecule determine receptor activation geometry.

View on PubMed

All studies referenced are independent third-party research. UNIK LAB makes no claims regarding the therapeutic efficacy of any compound and does not represent or endorse the conclusions of cited studies. All referenced research was conducted under controlled laboratory or clinical conditions; results may not be predictive of effects in other experimental contexts.

Common Questions

Research FAQ

Answers to the most frequently asked questions about Recombinant Human Growth Hormone.

Same Category

Similar Compounds

Other Growth Hormone research compounds from our catalogue.

Your Longevity Research Guide Awaits

Subscribe to receive new compound profiles, CoA updates, and curated research digests — delivered directly to your inbox.